Serotonin syndrome is a potentiallyfatalconditioncaused by overstimulation of serotonin receptors in the centraland peripheralnervous system. Serotonin syndrome developsdueto the increasedamount of serotonin duetoincreasedserotoninsynthesisorrelease, decreasedmetabolism, inhibition of reuptakeand / ordirectagonistic to serotonin receptors. Intheliterature, rarecases of serotoninsyndromeduetolinezolid have been reported. Inthisreport, wepresent a case of serotoninsyndromedeveloped in a patientreceivinglinezolid therapy fordiabetic foot infectionandreceivingescitalopramtreatment for major depression.
Serotoninsendromu merkezi ve periferik sinir sisteminde serotonin reseptörlerinin aşırı uyarılması sonucu gelişen ölümcül olabilen bir durumdur. Serotoninsendromu, serotoninsentezininin veya salınımının artması, metabolizmasının azalması, geri alımının inhibisyonu ve/veya serotonin reseptörlerine direk agonistik gibi nedenlere bağlı olarak artmış serotonin miktarına bağlı olarak gelişir. Bu sendrom en sıklıkla sorumlu ilacın aşırı dozu ve/veya ilaç etkileşimine bağlı olarak gelişebilir. Literatürde nadir de olsa linezolide bağlı serotoninsendromu vakaları bildirilmiştir. Bu sunumunda diyabetik ayak enfeksiyonu nedeniyle linezolid tedavisi alan, major depresyon nedeniyle esitalopram tedavisi de kullanan hastada gelişen Serotonin sendromu vakası sunulmak istendi.
___
1. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112-20.
2. Volpi-Abadie J, Kaye AM, Kaye AD. Serotonin syndrome. Ochsner J. 2013; 13:533-40.
3. 3.Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009; 60: 355-66.
4. Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. Br J Anaesth. 2005; 95: 434-41.
5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther.1981;30:239–45.
6. Sahiner V, Erden SO. Serotonin syndrome associated with linezolid use: a case report. Turk Psikiyatri Derg. 2009; 20(4): 398–402.
7. Samartzis L, Savvari P, Kontogiannis S, Dimopoulos S. Linezolid is associated with serotonin syndrome in a patient receiving amitriptyline, and fentanyl: a case report and review of the literature. Case Rep Psychiatry. 2013; 2013:617251.
8. Woytowish MR, Maynor LM. Clinical relevance of linezolid-associated serotonin toxicity. Ann Pharmacother. 2013;47:388-97.
9. Sanyal D, Chakraborty S, Bhattacharyya R. An interesting case of serotonin syndrome precipitated by escitalopram. Indian J Pharmacol. 2010;42:418–9.
10. Gelener P, Gorgulu U, Kutlu G, Ucler S, Inan LE. Serotonin syndrome due to duloxetine. Clin Neuropharmacol. 2011;34:127-8.
11. Lee J, Franz L, Goforth HW. Serotonin syndrome in a chronic-pain patient receiving concurrent methadone, ciprofloxacin, and venlafaxine. Psychosomatics. 2009;50:638–9.
12. Altınyazar V. Psikiyatride Güncel Yaklaşımlar Current Approaches in Psychiatry. 2010;2: 53271.
13. Sarısoy G, Kaçar ÖF, Pazvantoğlu O. Duloksetin-siprofloksasin birlikte kullanımıyla ilişkili serotonin sendromu: Olgu bildirimi. Klinik Psikofarmakoloji Bülteni. 2012; 22:79-82.
14. Özdemir S, Kocabaşoğlu N. Serotonin Sendromuna Güncel Bir Yaklaşım. Klinik Psikofarmakoloji Bülteni. 2007;17:217-25.
15. Taylor JJ, Wilson JW, Estes LL. Linezolid and serotonergic drug interactions: a retrospective survey. Clin Infect Dis. 2006;43:180-7.